InsideTrading SEC Form 4 insider trades
← All clusters
ITOS

iTeos Therapeutics, Inc.

Limited buying: $90.3M bought (counted up to $5.0M); 4 distinct insiders. Holding it back: largest buyer: LEWIS JOSEPH (10% owner), 60% of the dollars.

44
Insider ScoreThe number from 0 to 100 shown on each cluster and used to rank the lists. By default it is the match score, plus the points of the AI review when there is one. It describes the buying; it is not a forecast or a recommendation. <60 · limited buying
-160.3%
Since the cluster formed, vs benchmark (-45.1% raw)

Score, not a recommendation.

Total bought$90.3M18 Form 4 purchases
Distinct insiders4open-market buyers
Insiders' average price$19.00no recent close
Cluster window2020-07-28single day · closed

partial dataAn input is missing, usually the market cap or the price history. A missing input counts as neutral in the score and is never estimated. Market cap is missing; missing inputs count as neutral in the score.

same price, one day All 18 purchases were at $19.00 on 2020-07-28. That pattern also occurs in IPO or conversion subscriptions, which are not open-market conviction buying.

Price and insider purchases

Live chart from Yahoo Finance, loaded through this server; our daily closes when it is unavailable.

Loading price history…

How the score adds up

How each input is counted →
Points each input adds to the score, and how much of the points it could give it has
Input Strength Points
$90.3M bought (counted up to $5.0M)The dollars the insiders bought, a purchase reported jointly counted once, counted from $131. Each tenfold adds 12.4 points, up to $5.0M; more adds nothing. The bar is empty at $10.0K and full at $5.0M. 100% +57
4 distinct insidersHow many different insiders bought. Each extra insider adds less than the one before (the points follow the log of the count: 4.3 per doubling). The bar is full at 10 insiders. 60% +9
No CEO among the buyersWhether the chief executive is among the buyers: 10.6 points when yes. 0% +0
Stock 0% below its 1-year highHow far the stock had fallen from its highest close of the past year, at the close before the buying. Every 10% of fall adds 1.9 points. A fall beyond 30% adds nothing more. The bar is full at a 30% fall. 0% +0
0 days from first to last purchaseDays between the first and the last purchase. Each day takes off 0.11 points: buying close together keeps more. The bar is empty at 60 days. 100% +0
Routine or plan purchases: 0% of the dollarsThe share of the dollars in routine or plan purchases (a Rule 10b5-1 plan, dividend reinvestment, a regular cadence). All of it routine would take off 5.6 points. 100% +0
Largest buyer: LEWIS JOSEPH (10% owner), 60% of the dollarsThe share of the dollars bought by the largest buyer. Buying spread evenly keeps the points; one buyer paying for everything takes off 12.7. 53% -8
Match scoreA score from 0 to 100 worked out from the dollars bought, the number of insiders, whether a CEO bought, how far the stock had fallen, how spread out the purchases were and how much came from one buyer. Its weights were calibrated on past clusters. It is the default ranking of the lists and it decides which clusters get the AI review. It describes the buying; it is not a forecast.58
Pipeline flagsPoints taken off because the filings themselves show this buying was an offering, a plan or a 10b5-1 programme. Used only when there is no AI review; from Form 4 footnotes, 8-K filings and prices. (IPO or offering)-14
Insider ScoreThe number from 0 to 100 shown on each cluster and used to rank the lists. By default it is the match score, plus the points of the AI review when there is one. It describes the buying; it is not a forecast or a recommendation.44

Why are they buying?

No explanation has been generated for this cluster. The filings in the table below are the primary evidence.

Transactions

18 Form 4 trades · 5 insiders Download CSV Up to 5,000 rows
Purchases in this cluster, grouped by insider, largest first
Date InsiderAn officer or director of a company, or an owner of more than 10% of its shares. The law requires them to report their trades in the company's stock to the SEC. Role Shares Price Value Flags Filing
2020-07-28 RA CAPITAL MANAGEMENT, L.P. history of RA CAPITAL MANAGEMENT, L.P.'s purchases 10% owner 1,425,000 $19.00 $27.1M
offering
SEC filing for RA CAPITAL MANAGEMENT, L.P. (opens in a new tab)
2020-07-28 LEWIS JOSEPH history of LEWIS JOSEPH's purchases 10% owner 1,425,000 $19.00 avg $27.1M
offering
2020-07-28 LEWIS JOSEPH 1,401,448 $19.00 $26.6M
offering
SEC filing for LEWIS JOSEPH (opens in a new tab)
2020-07-28 LEWIS JOSEPH 23,552 $19.00 $447.5K
offering
SEC filing for LEWIS JOSEPH (opens in a new tab)
2020-07-28 Davis Aaron I. history of Davis Aaron I.'s purchases Director 1,425,000 $19.00 avg $27.1M
offering
2020-07-28 Davis Aaron I. 23,552 $19.00 $447.5K
offering
SEC filing for Davis Aaron I. (opens in a new tab)
2020-07-28 Davis Aaron I. 1,401,448 $19.00 $26.6M
offering
SEC filing for Davis Aaron I. (opens in a new tab)
2020-07-28 GADICKE ANSBERT history of GADICKE ANSBERT's purchases Director 320,000 $19.00 avg $6.1M
offering
2020-07-28 GADICKE ANSBERT 56,814 $19.00 $1.1M
offering
SEC filing for GADICKE ANSBERT (opens in a new tab)
2020-07-28 GADICKE ANSBERT 3,096 $19.00 $58.8K
offering
SEC filing for GADICKE ANSBERT (opens in a new tab)
2020-07-28 GADICKE ANSBERT 5,994 $19.00 $113.9K
offering
SEC filing for GADICKE ANSBERT (opens in a new tab)
2020-07-28 GADICKE ANSBERT 160,000 $19.00 $3.0M
offering
SEC filing for GADICKE ANSBERT (opens in a new tab)
2020-07-28 GADICKE ANSBERT 1,121 $19.00 $21.3K
offering
SEC filing for GADICKE ANSBERT (opens in a new tab)
2020-07-28 GADICKE ANSBERT 89,955 $19.00 $1.7M
offering
SEC filing for GADICKE ANSBERT (opens in a new tab)
2020-07-28 GADICKE ANSBERT 3,020 $19.00 $57.4K
offering
SEC filing for GADICKE ANSBERT (opens in a new tab)
2020-07-28 MPM BioVentures 2014, L.P. history of MPM BioVentures 2014, L.P.'s purchases 10% owner 160,000 $19.00 avg $3.0M
offering
2020-07-28 MPM BioVentures 2014, L.P. 1,121 $19.00 $21.3K
offering
SEC filing for MPM BioVentures 2014, L.P. (opens in a new tab)
2020-07-28 MPM BioVentures 2014, L.P. 3,020 $19.00 $57.4K
offering
SEC filing for MPM BioVentures 2014, L.P. (opens in a new tab)
2020-07-28 MPM BioVentures 2014, L.P. 56,814 $19.00 $1.1M
offering
SEC filing for MPM BioVentures 2014, L.P. (opens in a new tab)
2020-07-28 MPM BioVentures 2014, L.P. 3,096 $19.00 $58.8K
offering
SEC filing for MPM BioVentures 2014, L.P. (opens in a new tab)
2020-07-28 MPM BioVentures 2014, L.P. 5,994 $19.00 $113.9K
offering
SEC filing for MPM BioVentures 2014, L.P. (opens in a new tab)
2020-07-28 MPM BioVentures 2014, L.P. 89,955 $19.00 $1.7M
offering
SEC filing for MPM BioVentures 2014, L.P. (opens in a new tab)
Total $90.3M

What happened next

A buying runPurchases at one company with no pause longer than the cluster rule allows. A long pause ends the run, so one company can have several. ends after a pause in the buying, so one company can have several. Returns are the stock's return minus its benchmarkThe index a stock's return is compared with: a small-cap index for small companies, a large-cap index otherwise. (IWM for small companies, SPY otherwise), from the first open after the buying run became a cluster. Past results, not a forecast.

After this buying run became a cluster, vs benchmark: 21 days +47.0% (+55.9% raw)63 days +17.9% (+19.7% raw)126 days +52.6% (+68.5% raw)